top of page
Writer's pictureCapio Biosciences

Capio Biosciences Receives Notice of Allowance from Korean Intellectual Property Office

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for patent application # 10-2017-7035887 - "Method for monitoring efficacy of a cancer therapy using Circulating Tumor Cells as a biomarker” from the Korean Intellectual Property Office (KIPO). This patent, exclusively licensed to Capio Biosciences by the Board of Trustees of the University of Illinois; and the University of North Carolina at Chapel Hill, further strengthens the intellectual property portfolio of Capio Biosciences, and is another step toward clinical translation of CapioCyte™ technology.





0 comments

Comments


bottom of page